
What if the work you did every day could impact the lives of people you know? Or all of humanity?At Illumina, we are expanding access to genomic technology to realize health equity for billions of people around the world. Our efforts enable life-changing discoveries that are transforming human health through the early detection and diagnosis of diseases and new treatment options for patients.Working at Illumina means being part of something bigger than yourself. Every person, in every role, has the opportunity to make a difference. Surrounded by extraordinary people, inspiring leaders, and world changing projects, you will do more and become more than you ever thought possible.
Internal Title: Sr Product Engineer
The High Performance Computing (HPC) Engineer is responsible for ensuring the Linux-based computer used in Illumina Sequencing Platforms meeting all the functionality, security and robustness requirements. This role requires deep understanding of modern HPC architecture with the ability to optimize / finetune system performance, with benchmarking to identify system bottleneck.
The role involves in testing and evaluating HPC memory, CPU and network performance, with analysis of HPC Workload, Job Scheduling and CPU profiling. This position supports both New Product Introduction (NPI) and on-market activities within Instrument Operations and serves as a key interface with product development teams in Singapore and the US. This role collaborates cross-functionally to drive product and process enhancements, cost optimization, and operational excellence, enabling smooth transition from design to production, and sustaining high-performance standards throughout the product lifecycle.
Position Responsibilities:
Engage early with the development team to understand HPC system level design and interactions with different functional components such as EE, Software/Firmware, Operating System, FPGA
Diagnose HPC low-level performance bottlenecks across CPU, RAM, storage, networking and peripheral drivers.
Collaborate with software, hardware, and systems engineering teams to qualify new software, hardware and operating workflow for the HPC.
Evaluate hardware components including CPUs, memory, storage, networking, and peripheral devices for platform continuity and develop sustainable solutions
Established work instruction of HPC integration workflow, test procedure and diagnostic workflows for engineering and manufacturing use.
Conduct comprehensive root-cause investigations for complex production issues using structured problem-solving methodologies (FMEA, DOE, and statistical analysis).
Complete Non-conformance Records based on investigation outcomes and drive the release of instruments back into production.
Plan and execute engineering studies to support experiments and data collection efforts.
Participate in continuous improvement initiatives and operational excellence programs.
Write and update work instructions as needed to improve test procedures.
Listed responsibilities are an essential, but not exhaustive list, of the usual duties associated with the position. Changes to individual responsibilities may occur due to business needs.
Position Requirements:
All listed requirements are deemed as essential functions to this position; however, business conditions may require reasonable accommodations for additional task and responsibilities.
We are a company deeply rooted in belonging, promoting an inclusive environment where employees feel valued and empowered to contribute to our mission. Built on a strong foundation, Illumina has always prioritized openness, collaboration, and seeking alternative perspectives to propel innovation in genomics. We are proud to confirm a zero-net gap in pay, regardless of gender, ethnicity, or race. We also have several Employee Resource Groups (ERG) that deliver career development experiences, increase cultural awareness, and offer opportunities to engage in social responsibility. We are proud to be an equal opportunity employer committed to providing employment opportunity regardless of sex, race, creed, color, gender, religion, marital status, domestic partner status, age, national origin or ancestry, physical or mental disability, medical condition, sexual orientation, pregnancy, military or veteran status, citizenship status, and genetic information. Illumina conducts background checks on applicants for whom a conditional offer of employment has been made. Qualified applicants with arrest or conviction records will be considered for employment in accordance with applicable local, state, and federal laws. Background check results may potentially result in the withdrawal of a conditional offer of employment. The background check process and any decisions made as a result shall be made in accordance with all applicable local, state, and federal laws. Illumina prohibits the use of generative artificial intelligence (AI) in the application and interview process. If you require accommodation to complete the application or interview process, please contact accommodations@illumina.com. To learn more, visit: https://www.dol.gov/ofccp/regs/compliance/posters/pdf/eeopost.pdf. The position will be posted until a final candidate is selected or the requisition has a sufficient number of qualified applicants.

At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina’s innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.